vs

Side-by-side financial comparison of ESSENTIAL PROPERTIES REALTY TRUST, INC. (EPRT) and 4D Molecular Therapeutics, Inc. (FDMT). Click either name above to swap in a different company.

ESSENTIAL PROPERTIES REALTY TRUST, INC. is the larger business by last-quarter revenue ($158.8M vs $85.1M, roughly 1.9× 4D Molecular Therapeutics, Inc.). ESSENTIAL PROPERTIES REALTY TRUST, INC. runs the higher net margin — 37.8% vs 22.8%, a 15.0% gap on every dollar of revenue. On growth, 4D Molecular Therapeutics, Inc. posted the faster year-over-year revenue change (8508900.0% vs 22.8%). Over the past eight quarters, 4D Molecular Therapeutics, Inc.'s revenue compounded faster (5412.6% CAGR vs 20.6%).

Essential Properties Realty Trust is a publicly traded real estate investment trust (REIT) that acquires, owns and manages a diversified portfolio of single-tenant net-leased commercial properties across the United States. Its assets primarily cover essential service-oriented sectors including casual dining, automotive services, medical clinics, early childhood education centers and light industrial facilities, with tenants mostly holding robust long-term operating track records.

4D Molecular Therapeutics is a clinical-stage biotechnology company specializing in the research and development of targeted adeno-associated virus (AAV) gene therapies. Its core product candidates address unmet medical needs in ophthalmology, cardiology, and pulmonary disease segments, serving global patient populations with rare and common hard-to-treat conditions.

EPRT vs FDMT — Head-to-Head

Bigger by revenue
EPRT
EPRT
1.9× larger
EPRT
$158.8M
$85.1M
FDMT
Growing faster (revenue YoY)
FDMT
FDMT
+8508877.2% gap
FDMT
8508900.0%
22.8%
EPRT
Higher net margin
EPRT
EPRT
15.0% more per $
EPRT
37.8%
22.8%
FDMT
Faster 2-yr revenue CAGR
FDMT
FDMT
Annualised
FDMT
5412.6%
20.6%
EPRT

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
EPRT
EPRT
FDMT
FDMT
Revenue
$158.8M
$85.1M
Net Profit
$60.0M
$19.4M
Gross Margin
Operating Margin
56.5%
17.3%
Net Margin
37.8%
22.8%
Revenue YoY
22.8%
8508900.0%
Net Profit YoY
6.5%
139.1%
EPS (diluted)
$0.28
$0.43

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EPRT
EPRT
FDMT
FDMT
Q1 26
$158.8M
Q4 25
$149.9M
$85.1M
Q3 25
$144.9M
$90.0K
Q2 25
$137.1M
$15.0K
Q1 25
$129.4M
$14.0K
Q4 24
$119.7M
$1.0K
Q3 24
$117.1M
$3.0K
Q2 24
$109.3M
$5.0K
Net Profit
EPRT
EPRT
FDMT
FDMT
Q1 26
$60.0M
Q4 25
$68.1M
$19.4M
Q3 25
$65.6M
$-56.9M
Q2 25
$63.2M
$-54.7M
Q1 25
$56.1M
$-48.0M
Q4 24
$55.4M
Q3 24
$49.1M
$-43.8M
Q2 24
$51.5M
$-35.0M
Operating Margin
EPRT
EPRT
FDMT
FDMT
Q1 26
56.5%
Q4 25
65.9%
17.3%
Q3 25
64.7%
-67983.3%
Q2 25
64.1%
-396373.3%
Q1 25
61.6%
-383007.1%
Q4 24
66.1%
Q3 24
59.7%
-1704400.0%
Q2 24
61.1%
-849120.0%
Net Margin
EPRT
EPRT
FDMT
FDMT
Q1 26
37.8%
Q4 25
45.4%
22.8%
Q3 25
45.3%
-63195.6%
Q2 25
46.1%
-364386.7%
Q1 25
43.4%
-342657.1%
Q4 24
46.3%
Q3 24
42.0%
-1461433.3%
Q2 24
47.1%
-699060.0%
EPS (diluted)
EPRT
EPRT
FDMT
FDMT
Q1 26
$0.28
Q4 25
$0.34
$0.43
Q3 25
$0.33
$-1.01
Q2 25
$0.32
$-0.98
Q1 25
$0.29
$-0.86
Q4 24
$0.31
Q3 24
$0.27
$-0.79
Q2 24
$0.29
$-0.63

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EPRT
EPRT
FDMT
FDMT
Cash + ST InvestmentsLiquidity on hand
$15.2M
$402.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$4.4B
$505.7M
Total Assets
$7.2B
$566.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EPRT
EPRT
FDMT
FDMT
Q1 26
$15.2M
Q4 25
$60.2M
$402.7M
Q3 25
$23.8M
$305.1M
Q2 25
$20.8M
$293.2M
Q1 25
$47.0M
$321.4M
Q4 24
$40.7M
$424.9M
Q3 24
$32.7M
$501.9M
Q2 24
$23.6M
$541.9M
Total Debt
EPRT
EPRT
FDMT
FDMT
Q1 26
Q4 25
$2.5B
Q3 25
$2.6B
Q2 25
$2.3B
Q1 25
$2.1B
Q4 24
$2.1B
Q3 24
$2.2B
Q2 24
$1.9B
Stockholders' Equity
EPRT
EPRT
FDMT
FDMT
Q1 26
$4.4B
Q4 25
$4.2B
$505.7M
Q3 25
$3.8B
$369.0M
Q2 25
$3.8B
$420.9M
Q1 25
$3.8B
$469.7M
Q4 24
$3.6B
$510.6M
Q3 24
$3.2B
$552.9M
Q2 24
$3.2B
$588.3M
Total Assets
EPRT
EPRT
FDMT
FDMT
Q1 26
$7.2B
Q4 25
$6.9B
$566.7M
Q3 25
$6.6B
$424.0M
Q2 25
$6.3B
$473.6M
Q1 25
$6.1B
$515.7M
Q4 24
$5.8B
$560.4M
Q3 24
$5.5B
$604.0M
Q2 24
$5.3B
$620.1M
Debt / Equity
EPRT
EPRT
FDMT
FDMT
Q1 26
Q4 25
0.60×
Q3 25
0.69×
Q2 25
0.61×
Q1 25
0.56×
Q4 24
0.60×
Q3 24
0.69×
Q2 24
0.59×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EPRT
EPRT
FDMT
FDMT
Operating Cash FlowLast quarter
$28.6M
Free Cash FlowOCF − Capex
$28.5M
FCF MarginFCF / Revenue
33.5%
Capex IntensityCapex / Revenue
0.1%
Cash ConversionOCF / Net Profit
1.47×
TTM Free Cash FlowTrailing 4 quarters
$-109.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EPRT
EPRT
FDMT
FDMT
Q1 26
Q4 25
$381.1M
$28.6M
Q3 25
$99.0M
$-46.5M
Q2 25
$99.8M
$-43.4M
Q1 25
$77.2M
$-47.8M
Q4 24
$308.5M
$-134.6M
Q3 24
$73.5M
$-29.4M
Q2 24
$81.1M
$-30.2M
Free Cash Flow
EPRT
EPRT
FDMT
FDMT
Q1 26
Q4 25
$28.5M
Q3 25
$-46.6M
Q2 25
$-43.4M
Q1 25
$-48.4M
Q4 24
$-138.4M
Q3 24
$-31.2M
Q2 24
$-30.6M
FCF Margin
EPRT
EPRT
FDMT
FDMT
Q1 26
Q4 25
33.5%
Q3 25
-51765.6%
Q2 25
-289620.0%
Q1 25
-345635.7%
Q4 24
-13837100.0%
Q3 24
-1038966.7%
Q2 24
-611840.0%
Capex Intensity
EPRT
EPRT
FDMT
FDMT
Q1 26
Q4 25
0.1%
Q3 25
101.1%
Q2 25
440.0%
Q1 25
4507.1%
Q4 24
378600.0%
Q3 24
59266.7%
Q2 24
6980.0%
Cash Conversion
EPRT
EPRT
FDMT
FDMT
Q1 26
Q4 25
5.60×
1.47×
Q3 25
1.51×
Q2 25
1.58×
Q1 25
1.38×
Q4 24
5.57×
Q3 24
1.50×
Q2 24
1.57×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

EPRT
EPRT

Rental revenue 1,2$149.4M94%
Other$8.6M5%
Other revenue$779.0K0%

FDMT
FDMT

Segment breakdown not available.

Related Comparisons